Accelerating molecular innovation through a stronger global supply chain. Synbio Technologies, a global molecular manufacturing company specializing in synthetic biology-enabled solutions, is proud to announce a strategic distribution partnership with VWR International, one of the world’s leading laboratory product and service distributors.

This collaboration marks an important milestone in expanding global access to advanced molecular manufacturing capabilities, enabling researchers to obtain cutting-edge synthetic biology products and services with greater speed, convenience, and reliability.

With more than 170 years of industry experience and operations spanning over 180 countries, VWR International has built one of the most extensive laboratory supply networks worldwide, offering millions of laboratory consumables, instruments, chemicals, and related services. Through this strategic partnership, Synbio Technologies’ molecular manufacturing portfolio will become more accessible to scientists and organizations worldwide through an established and trusted procurement ecosystem.

The partnership also strengthens VWR’s offering in synthetic biology and molecular manufacturing, while creating a more integrated “supply-to-application” ecosystem for Synbio Technologies to better support scientific innovation from concept to execution.

“We are breaking down geographic and supply chain barriers to accelerate innovation,” said Ping Yang, CEO of Synbio Technologies. “Our collaboration with VWR makes advanced molecular manufacturing solutions as accessible as standard laboratory supplies, empowering scientists around the world to move faster from ideas to validated outcomes.”

By combining Synbio Technologies’ expertise in molecular manufacturing with VWR’s global distribution capabilities, the partnership is designed to help researchers turn scientific possibilities into practical realities—faster and more efficiently.

About Synbio Technologies

Synbio Technologies is a globally recognized molecular manufacturing company powered by an AI-enabled synthetic biology technology platform. Focused on DNA, RNA, proteins, antibodies, and related biomolecule manufacturing services, the company provides integrated, end-to-end solutions for academic researchers, biotechnology companies, and pharmaceutical organizations worldwide, helping accelerate research, development, and production workflows.